Literature DB >> 20875496

High tetanus antitoxin antibody concentrations in the Netherlands: a seroepidemiological study.

Anneke Steens1, L Mollema, G A M Berbers, P G M van Gageldonk, F R van der Klis, H E de Melker.   

Abstract

We assessed the level and determinants of tetanus-antitoxin (TT)-antibodies in the Dutch population. Additionally, we evaluated the national guidelines for post-exposure prophylaxis. Serum samples and questionnaire data from a cross-sectional, population-based study were obtained from 7903 individuals. Serum antitoxin antibodies were assessed with a multiplex immunoassay. Multivariable linear regression was used to explore factors associated with antibody concentration. The overall seroprevalence was 94% with a geometric mean concentration (GMC) of 0.91 IU/ml. The TT-GMC increased with age in the age-cohorts of 13-23 years, which coincides with the meningococcal C conjugate mass-vaccination in 2002. Lower seroprevalences were found in individuals born before introduction of routine vaccination, first-generation migrants from non-Western countries born before 1984, and conservative Protestants living in the Dutch 'Bible belt'. Only 10% of those eligible for post-exposure prophylaxis were not sufficiently protected against tetanus.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20875496     DOI: 10.1016/j.vaccine.2010.09.036

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Improved specificity of a multiplex immunoassay for quantitation of anti-diphtheria toxin antibodies with the use of diphtheria toxoid.

Authors:  Pieter G M van Gageldonk; Christina von Hunolstein; Fiona R M van der Klis; Guy A M Berbers
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

Review 2.  Vaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence.

Authors:  Daniele Mipatrini; Paola Stefanelli; Santino Severoni; Giovanni Rezza
Journal:  Pathog Glob Health       Date:  2017-02-06       Impact factor: 2.894

3.  Non-protective immunity against tetanus in primiparous women and newborns at birth in rural and urban settings in Ibadan, Nigeria.

Authors:  Adebola Emmanuel Orimadegun; Bose Etaniamhe Orimadegun; Elijah Afolabi Bamgboye
Journal:  Pan Afr Med J       Date:  2017-06-23

4.  The use of tetanus post-exposure prophylaxis guidelines by general practitioners and emergency departments in the Netherlands: a cross-sectional questionnaire study.

Authors:  Robine Donken; Nicoline van der Maas; Corien Swaan; Tjerk Wiersma; Margreet Te Wierik; Susan Hahné; Hester de Melker
Journal:  BMC Fam Pract       Date:  2014-06-09       Impact factor: 2.497

Review 5.  Factors contributing to the immunogenicity of meningococcal conjugate vaccines.

Authors:  Michael Bröker; Francesco Berti; Paolo Costantino
Journal:  Hum Vaccin Immunother       Date:  2016-03-02       Impact factor: 3.452

6.  Novel Intervention in the Aging Population: A Primary Meningococcal Vaccine Inducing Protective IgM Responses in Middle-Aged Adults.

Authors:  Marieke van der Heiden; Annemieke M H Boots; Axel A Bonacic Marinovic; Lia G H de Rond; Marjan van Maurik; Irina Tcherniaeva; Guy A M Berbers; Anne-Marie Buisman
Journal:  Front Immunol       Date:  2017-07-19       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.